Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver
- PMID:2492107
- PMCID: PMC286490
- DOI: 10.1073/pnas.86.2.462
Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver
Abstract
In vitro studies with human liver indicate that the major catalyst involved in the bioactivation of the hepato-carcinogen aflatoxin B1 (AFB1) to its genotoxic 2,3-epoxide derivative is cytochrome P-450NF (P-450NF), a previously characterized protein that also catalyzes the oxidation of nifedipine and other dihydropyridines, quinidine, macrolide antibiotics, various steroids, and other compounds. Evidence was obtained using activation of AFB1 as monitored by umuC gene expression response in Salmonella typhimurium TA1535/pSK1002 and enzyme reconstitution, immunochemical inhibition, correlation of response with levels of P-450NF and nifedipine oxidase activity in different liver samples, stimulation of activity by 7,8-benzoflavone, and inhibition of activity by troleandomycin. Similar results were obtained when levels of 2,3-dihydro-2-(N7-guanyl)-3-hydroxyaflatoxin B1 formed in DNA were measured. P-450NF or a closely related protein also appears to be the major catalyst involved in the activation of aflatoxin G1 and sterigmatocystin, the latter compound being more genotoxic than AFB1 in these systems. Several drugs and conditions are known to influence the levels and activity of P-450NF in human liver, and the activity of the enzyme can be estimated by noninvasive assays. These findings provide a test system for the hypothesis that a specific human disease state (liver cancer) is linked to the level of oxidative metabolism in populations in which aflatoxin ingestion is high.
Similar articles
- Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.Shimada T, Iwasaki M, Martin MV, Guengerich FP.Shimada T, et al.Cancer Res. 1989 Jun 15;49(12):3218-28.Cancer Res. 1989.PMID:2655891
- Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.Baertschi SW, Raney KD, Shimada T, Harris TM, Guengerich FP.Baertschi SW, et al.Chem Res Toxicol. 1989 Mar-Apr;2(2):114-2. doi: 10.1021/tx00008a008.Chem Res Toxicol. 1989.PMID:2519710
- Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.Ramsdell HS, Parkinson A, Eddy AC, Eaton DL.Ramsdell HS, et al.Toxicol Appl Pharmacol. 1991 May;108(3):436-47. doi: 10.1016/0041-008x(91)90090-2.Toxicol Appl Pharmacol. 1991.PMID:1902334
- Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity.Hsieh DP, Atkinson DN.Hsieh DP, et al.Adv Exp Med Biol. 1991;283:525-32. doi: 10.1007/978-1-4684-5877-0_69.Adv Exp Med Biol. 1991.PMID:1906226Review.
- Hepatic metabolism and bioactivation of mycotoxins and plant toxins.Swick RA.Swick RA.J Anim Sci. 1984 Apr;58(4):1017-28. doi: 10.2527/jas1984.5841017x.J Anim Sci. 1984.PMID:6373704Review.
Cited by
- Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.Forrester LM, Neal GE, Judah DJ, Glancey MJ, Wolf CR.Forrester LM, et al.Proc Natl Acad Sci U S A. 1990 Nov;87(21):8306-10. doi: 10.1073/pnas.87.21.8306.Proc Natl Acad Sci U S A. 1990.PMID:2122459Free PMC article.
- Ninety-eight semesters of cytochrome P450 enzymes and related topics-What have I taught and learned?Guengerich FP.Guengerich FP.J Biol Chem. 2024 Feb;300(2):105625. doi: 10.1016/j.jbc.2024.105625. Epub 2024 Jan 5.J Biol Chem. 2024.PMID:38185246Free PMC article.
- Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.Rendic SP, Guengerich FP.Rendic SP, et al.Curr Drug Metab. 2018;19(1):3-46. doi: 10.2174/1389200219666171207123939.Curr Drug Metab. 2018.PMID:29219051Free PMC article.Review.
- Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.Hayes JD, Judah DJ, McLellan LI, Kerr LA, Peacock SD, Neal GE.Hayes JD, et al.Biochem J. 1991 Oct 15;279 ( Pt 2)(Pt 2):385-98. doi: 10.1042/bj2790385.Biochem J. 1991.PMID:1953636Free PMC article.
- Distribution and induction of aflatoxin B1-9a-hydroxylase activity in rat liver parenchymal and non-parenchymal cells.Gemechu-Hatewu M, Platt KL, Oesch F, Steinberg P.Gemechu-Hatewu M, et al.Arch Toxicol. 1996;70(9):553-8. doi: 10.1007/s002040050312.Arch Toxicol. 1996.PMID:8831905
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases